1737 (1737) News
Follow 1737 (1737) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Taiyen Biotech Reports Third-Quarter Net Profit of NT$59.6 Million
Taiyen Biotech’s third-quarter revenue was NT$825.049 million, compared with NT$814.822 million a year earlier. Pretax profit was NT$79.67 million versus NT$100.121 million.
EQUITY | Nov 10, 2026, 06:56 AM UTC
M
Taiyen Biotech reports Sep revenue NT$273.0 million
Taiyen Biotech Co. Ltd. reported Sep revenue of NT$273,039,000 versus NT$265,400,000 in 2025. Jan–Sep revenue was NT$2,383,558,000 versus NT$2,491,208,000 in 2025.
EARNINGS | Oct 08, 2026, 06:06 AM UTC
L
Taiyen Biotech Aug revenue NT$275.0M vs NT$286.1M prior
Taiyen Biotech reported August revenue of NT$275,018,000, versus NT$286,105,000 for the prior year. Jan-Aug revenue was NT$2,110,519,000 versus NT$2,225,808,000.
EQUITY | Sep 08, 2026, 05:50 AM UTC